| Excerpt | Relevance | Reference |
|---|
| "Daunorubicin, thioguanine and cytosine arabinoside were administered from the 17th to 34th weeks of pregnancy in a 23-year-old patient with acute myeloid leukaemia." | 7.66 | Normal infant after treatment of acute myeloid leukaemia in pregnancy with daunorubicin. ( Baikie, MJ; Campbell, SN; Lowenthal, RM; Marsden, KA; Newman, NM, 1978) |
| "Daunorubicin, thioguanine and cytosine arabinoside were administered from the 17th to 34th weeks of pregnancy in a 23-year-old patient with acute myeloid leukaemia." | 3.66 | Normal infant after treatment of acute myeloid leukaemia in pregnancy with daunorubicin. ( Baikie, MJ; Campbell, SN; Lowenthal, RM; Marsden, KA; Newman, NM, 1978) |